Cancer glossary
Trastuzumab deruxtecan (Enhertu): for HER2-low and HER2+, and the main risk — the lungs
Trastuzumab deruxtecan is an antibody–drug conjugate. Who gets it, why it works in HER2-low cancer, and why a new cough or breathlessness must be reported straight away.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
Trastuzumab deruxtecan (brand name Enhertu) is an antibody–drug conjugate: an antibody to HER2 delivers a chemotherapy drug (a topoisomerase I inhibitor) directly to tumor cells. Its key feature is that it also works when HER2 expression is low — HER2-low.
How it appears in your prescription
- ‘Trastuzumab deruxtecan 5.4 mg/kg IV every 3 weeks’ — in breast cancer.
- In other indications the dose may differ.
What it means
According to the US National Cancer Institute, the drug is approved for metastatic HER2-positive and HER2-low breast cancer, HER2-positive stomach cancer, non-small cell lung cancer with a HER2 mutation, and some other solid tumors with high HER2 expression. It is usually given after earlier lines of treatment. Approved uses in each country are set by the local label and guidelines.
Side effects
Common ones are nausea (anti-sickness prophylaxis is needed), fatigue, hair loss and low neutrophils and other blood counts. The main serious risk is interstitial lung disease (pneumonitis). Chest CT scans are done before and during treatment as your doctor plans.
Tell your doctor straight away about a new cough, shortness of breath or fever — even if it feels like a cold.
Questions to ask your doctor
- Does my HER2 status fit — 1+, 2+ without amplification, or positive?
- How will my lungs be monitored, and how often will I have a CT?
- What anti-sickness prophylaxis will I get?
Sources
- Fam-Trastuzumab Deruxtecan-nxki — National Cancer Institute
- Targeted Therapy for Breast Cancer — National Cancer Institute
- Breast Cancer HER2 Status — American Cancer Society
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
